Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T R Chauncey

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Blood|May 15, 1997
Improved reconstitution of CD4 T cells and B cells but worsened reconstitution of serum IgG levels after allogeneic transplantation of blood stem cells instead of marrowJ Storek, R P Witherspoon, D G Maloney, et al.
British Journal of Haematology|November 5, 1997
Allogeneic marrow transplantation for primary myelofibrosis and myelofibrosis secondary to polycythaemia vera or essential thrombocytosisJ E Anderson, G Sale, F R Appelbaum, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 13, 1998
A study of the pharmacokinetics, antiviral activity, and tolerability of oral ganciclovir for CMV prophylaxis in marrow transplantationM Boeckh, J A Zaia, D Jung, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 17, 2001
Relapse after allogeneic bone marrow transplantation for refractory anemia is increased by shielding lungs and liver during total body irradiationJ E Anderson, F R Appelbaum, G Schoch, et al.
The American Journal of Surgical Pathology|July 15, 2000
Bile duct apoptosis and cholestasis resembling acute graft-versus-host disease after autologous hematopoietic cell transplantationM D Saunders, H M Shulman, C S Murakami, et al.
American Journal of Clinical Oncology|August 24, 2000
Pilot trial of cytoprotection with amifostine given with high-dose chemotherapy and autologous peripheral blood stem cell transplantationT R Chauncey, T A Gooley, M E Lloid, et al.
Leukemia|November 5, 2005
Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysisB L Scott, B M Sandmaier, B Storer, et al.
Leukemia|March 18, 2005
High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantationF Baron, M B Maris, B E Storer, et al.
Blood|November 24, 2001
CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantationJ M Zaucha, T Gooley, W I Bensinger, et al.
The New England Journal of Medicine|February 15, 2001
Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancersW I Bensinger, P J Martin, B Storer, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Blood|May 15, 1997
Improved reconstitution of CD4 T cells and B cells but worsened reconstitution of serum IgG levels after allogeneic transplantation of blood stem cells instead of marrowJ Storek, R P Witherspoon, D G Maloney, et al.
British Journal of Haematology|November 5, 1997
Allogeneic marrow transplantation for primary myelofibrosis and myelofibrosis secondary to polycythaemia vera or essential thrombocytosisJ E Anderson, G Sale, F R Appelbaum, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 13, 1998
A study of the pharmacokinetics, antiviral activity, and tolerability of oral ganciclovir for CMV prophylaxis in marrow transplantationM Boeckh, J A Zaia, D Jung, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 17, 2001
Relapse after allogeneic bone marrow transplantation for refractory anemia is increased by shielding lungs and liver during total body irradiationJ E Anderson, F R Appelbaum, G Schoch, et al.
The American Journal of Surgical Pathology|July 15, 2000
Bile duct apoptosis and cholestasis resembling acute graft-versus-host disease after autologous hematopoietic cell transplantationM D Saunders, H M Shulman, C S Murakami, et al.
American Journal of Clinical Oncology|August 24, 2000
Pilot trial of cytoprotection with amifostine given with high-dose chemotherapy and autologous peripheral blood stem cell transplantationT R Chauncey, T A Gooley, M E Lloid, et al.
Leukemia|November 5, 2005
Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysisB L Scott, B M Sandmaier, B Storer, et al.
Leukemia|March 18, 2005
High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantationF Baron, M B Maris, B E Storer, et al.
Blood|November 24, 2001
CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantationJ M Zaucha, T Gooley, W I Bensinger, et al.
The New England Journal of Medicine|February 15, 2001
Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancersW I Bensinger, P J Martin, B Storer, et al.
Pageof 4